Editorial: The US burden of HRS-AKI-Putting numbers to the problem
- PMID: 37307546
- DOI: 10.1111/apt.17541
Editorial: The US burden of HRS-AKI-Putting numbers to the problem
Comment in
-
Editorial: The US burden of HRS-AKI-Putting numbers to the problem: Authors' reply.Aliment Pharmacol Ther. 2023 Jul;58(1):122-123. doi: 10.1111/apt.17562. Aliment Pharmacol Ther. 2023. PMID: 37307544 No abstract available.
Comment on
-
Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US.Aliment Pharmacol Ther. 2022 Nov;56(10):1486-1496. doi: 10.1111/apt.17232. Epub 2022 Oct 5. Aliment Pharmacol Ther. 2022. PMID: 36196562
References
REFERENCES
-
- Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology. 2005;42(2):439-47.
-
- Ng CK, Chan MH, Tai MH, Lam CW. Hepatorenal syndrome. Clin Biochem Rev. 2007;28(1):11-7.
-
- Pant C, Jani BS, Desai M, Deshpande A, Pandya P, Taylor R, et al. Hepatorenal syndrome in hospitalized patients with chronic liver disease: results from the Nationwide inpatient sample 2002-2012. J Invest Med. 2016;64(1):33-8.
-
- Singh J, Dahiya DS, Kichloo A, Singh G, Khoshbin K, Shaka H. Hepatorenal syndrome: a nationwide trend analysis from 2008 to 2018. Ann Med. 2021;53(1):2018-24.
-
- Singal AK, Kuo Y-F, Reddy KR, Bataller R, Kwo P. Healthcare burden and outcomes of hepatorenal syndrome among cirrhosis-related hospitalisations in the US. Aliment Pharmacol Ther. 2022;56:1486-96. https://doi.org/10.1111/apt.17232